VEA
ABEO icon

Virtus ETF Advisers’s Abeona Therapeutics ABEO Stock Holding History

Virtus ETF Advisers’s Portfolio ABEO Stock Details ABEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-1,955
Closed -$110K – 453
2019
Q3 		$110K Sell
1,955
-109
-5% -$8.16K 0.02% 283
2019
Q2 		$247K Buy
2,064
+645
+45% +$108K 0.05% 278
2019
Q1 		$261K Sell
1,419
-182
-11% -$32.5K 0.56% 74
2018
Q4 		$286K Buy
1,601
+410
+34% +$89.4K 0.05% 128
2018
Q3 		$381K Sell
1,191
-851
-42% -$302K 0.04% 169
2018
Q2 		$817K Buy
2,042
+156
+8% +$68.2K 0.72% 22
2018
Q1 		$677K Buy
1,886
+1,012
+116% +$376K 0.59% 96
2017
Q4 		$346K Buy
+874
New +$361K 0.43% 96

Other funds holding ABEO

GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
CH
CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Virtus ETF Advisers's ABEO Position: Q4 2019 in Review

Virtus ETF Advisers sold out of Abeona Therapeutics (ABEO) in Q4 2019, closing a stake of 1,955 shares — an estimated $110K sold.

Virtus ETF Advisers first reported a position in ABEO in Q4 2017 and held it in 8 quarters. The position peaked at $817K in Q2 2018. 87 funds tracked by Wall St. Rank hold ABEO as of Q4 2019.

  • Virtus ETF Advisers reported no remaining Abeona Therapeutics position as of Q4 2019 after selling out during the quarter.
  • Virtus ETF Advisers sold 1,955 Abeona Therapeutics shares in Q4 2019, an estimated $110K.
  • Virtus ETF Advisers first reported a position in Abeona Therapeutics in Q4 2017 and held it in 8 quarters.
  • Virtus ETF Advisers's Abeona Therapeutics position peaked at $817K in Q2 2018.
  • 87 funds tracked by Wall St. Rank held Abeona Therapeutics as of Q4 2019.

Based on Virtus ETF Advisers's 13F filing for Q4 2019, filed 13 Feb 2020.